High Risk Localized Or Locally Advanced Prostate Adenocarcinoma clinical trials

Explore recruiting high risk localized or locally advanced prostate adenocarcinoma clinical trials.

Recruiting high risk localized or locally advanced prostate adenocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Risk Localized Or Locally Advanced Prostate Adenocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prostate Androgen Response Investigation using a Stratification BIOmarker - PARIS-BIO Predicting prostate cancer downstageing by neoadjuvant Darolutamide with PCAI ImmunoScore in a non-randomised open label prospective trial.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

High Risk Localized Or Locally Advanced Prostate Adenocarcinoma trials by city

High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Toronto High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Vancouver High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Montreal High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Calgary High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Edmonton High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Ottawa High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Winnipeg High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Quebec City High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Hamilton High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Kitchener High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in London High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Halifax High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in New York High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Los Angeles High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Chicago High Risk Localized Or Locally Advanced Prostate Adenocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease